Company Filing History:
Years Active: 2015
Title: Tae Bo Shim: Innovator in Cancer Treatment
Introduction
Tae Bo Shim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer treatment.
Latest Patents
Tae Bo Shim holds a patent for a novel compound titled "Purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against Raf kinase, containing same as active ingredient." This innovative compound effectively regulates the activity of B-Raf kinase, which is crucial in the prevention and treatment of various cancers, including melanoma, colorectal cancer, prostate cancer, thyroid cancer, and ovarian cancer. The patent highlights the potential of this compound in addressing cancers induced by the over-activation of Raf kinase.
Career Highlights
Tae Bo Shim is currently associated with Medpacto Inc., where he continues to advance his research and development efforts. His work is pivotal in the pharmaceutical industry, focusing on creating effective treatments for cancer patients.
Collaborations
Tae Bo Shim collaborates with notable colleagues, including Eun Kyong Shim and Nam Doo Kim, who contribute to his research endeavors and the development of innovative pharmaceutical solutions.
Conclusion
Tae Bo Shim's contributions to cancer treatment through his patented innovations demonstrate his commitment to improving healthcare outcomes. His work at Medpacto Inc. and collaborations with fellow researchers highlight the importance of teamwork in advancing medical science.